These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 333693)

  • 21. Evaluation of baclofen (Lioresal) for spasticity in multiple sclerosis.
    Hedley DW; Maroun JA; Espir ML
    Postgrad Med J; 1975 Sep; 51(599):615-8. PubMed ID: 1105499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Involvement of bladder neck and periurethral sphincter in dyssynergia in patients with spinal cord injury].
    Vírseda Chamorro M; Salinas Casado J; Allona Almagro A; Litton Muñoz M
    Arch Esp Urol; 2002 Apr; 55(3):293-302. PubMed ID: 12068761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical effects of multiple sclerosis therapy.
    Jaffe R
    Neurology; 1979 May; 29(5):760. PubMed ID: 375123
    [No Abstract]   [Full Text] [Related]  

  • 24. Baclofen in the treatment of spasticity.
    Hudgson P; Weightman D
    Br Med J; 1971 Oct; 4(5778):15-7. PubMed ID: 4938243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug therapy of neurogenic bladder with the alpha-receptor blocker phenoxybenzamine].
    Gebhardt K; Weber H
    Z Urol Nephrol; 1982 Dec; 75(12):857-61. PubMed ID: 7164611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind trial of baclofen against placebo in the treatment of schizophrenia.
    Gulmann NC; Bahr B; Andersen B; Eliassen HM
    Acta Psychiatr Scand; 1976 Oct; 54(4):287-93. PubMed ID: 793304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of neurogenic bladder using phenoxybenzamine and bethanechol in acute spinal cord lesions].
    Martínez Agulló E; Gallego Gómez J; Jiménez Cruz F; Gracia Pérez A
    Actas Urol Esp; 1983; 7(1):23-8. PubMed ID: 6136159
    [No Abstract]   [Full Text] [Related]  

  • 28. Letter: Baclofen.
    Pedersen E
    Arch Phys Med Rehabil; 1974 Nov; 55(11):526-7. PubMed ID: 4441269
    [No Abstract]   [Full Text] [Related]  

  • 29. Diagnostic discordance of electromyography (EMG) versus voiding cystourethrogram (VCUG) for detrusor-external sphincter dyssynergy (DESD).
    De EJ; Patel CY; Tharian B; Westney OL; Graves DE; Hairston JC
    Neurourol Urodyn; 2005; 24(7):616-21. PubMed ID: 16217787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Urological complications in patients with multiple sclerosis (author's transl)].
    Kiesswetter H; Flamm J; Hennrich F; Summer K; Schober W
    Wien Klin Wochenschr; 1980 Jan; 92(1):16-22. PubMed ID: 6929626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The urologic diagnosis and management of the reflex or upper motor neuron type of neurogenic bladder.
    Bryan R; Tomskey GC; Gilbert NS
    J La State Med Soc; 1968 Apr; 120(4):187-96. PubMed ID: 5651776
    [No Abstract]   [Full Text] [Related]  

  • 32. Over-distension therapy of the bladder in paraplegic patients using self-catheterisation: a preliminary study.
    Iwatsubo E; Komine S; Yamashita H; Imamura A; Akatsu T
    Paraplegia; 1984 Aug; 22(4):210-5. PubMed ID: 6483463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Memokath stents for the treatment of detrusor sphincter dyssynergia (DSD) in men with spinal cord injury: the Princess Royal Spinal Injuries Unit 10-year experience.
    Mehta SS; Tophill PR
    Spinal Cord; 2006 Jan; 44(1):1-6. PubMed ID: 16044169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Notching of the external urethral sphincter in the treatment of neurogenous micturition disorders. Experiences with paraplegics].
    Elsässer E
    Munch Med Wochenschr; 1973 Jan; 115(2):41-4. PubMed ID: 4739320
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial.
    Herschorn S; Gajewski J; Ethans K; Corcos J; Carlson K; Bailly G; Bard R; Valiquette L; Baverstock R; Carr L; Radomski S
    J Urol; 2011 Jun; 185(6):2229-35. PubMed ID: 21497851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful control of selective anterior sacral rhizotomy for treatment of spastic bladder and ureteric reflux in paraplegics.
    Nagib A; Leal J; Voris HC
    Med Serv J Can; 1966; 22(7):576-81. PubMed ID: 5966992
    [No Abstract]   [Full Text] [Related]  

  • 37. Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions.
    Klaphajone J; Kitisomprayoonkul W; Sriplakit S
    Arch Phys Med Rehabil; 2005 Nov; 86(11):2114-8. PubMed ID: 16271557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reflex activity of the detrusor to rectal and perianal stimulation in spinal cord lesions].
    Rossier A; Bors E
    Helv Chir Acta; 1965 Oct; 32(4):468-74. PubMed ID: 5843047
    [No Abstract]   [Full Text] [Related]  

  • 39. Baclofen, a new antispastic drug. A controlled, multicenter trial in patients with multiple sclerosis.
    Sachais BA; Logue JN; Carey MS
    Arch Neurol; 1977 Jul; 34(7):422-8. PubMed ID: 327987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB).
    Cruz F; Nitti V
    Neurourol Urodyn; 2014 Jul; 33 Suppl 3():S26-31. PubMed ID: 25042140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.